Deutsche Bank Sticks to Its Hold Rating for AbbVie (ABBV)
I'm PortAI, I can summarize articles.
Shin covers the Healthcare sector, focusing on stocks such as Eli Lilly & Co, Gilead Sciences, and AbbVie. According to TipRanks, Shin has an average return of -9.6% and a 40.00% success rate on recommended stocks. In addition to Deutsche Bank , AbbVie also received a Hold from TR | OpenAI – 4o’s Veda Pharmyne in a report issued on September 9. However, today, Cantor Fitzgerald maintained a Buy rating on AbbVie (NYSE: ABBV).
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments